Cargando…
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine effects concerning antibody seroconversion, inflammatory mediato...
Autores principales: | Mazziotti, Valentina, Crescenzo, Francesco, Tamanti, Agnese, Dapor, Caterina, Ziccardi, Stefano, Guandalini, Maddalena, Colombi, Annalisa, Camera, Valentina, Peloso, Angela, Pezzini, Francesco, Turano, Ermanna, Marastoni, Damiano, Calabrese, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775192/ https://www.ncbi.nlm.nih.gov/pubmed/36551795 http://dx.doi.org/10.3390/biomedicines10123034 |
Ejemplares similares
-
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021) -
Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF
por: Pezzini, Francesco, et al.
Publicado: (2023) -
The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study
por: Crescenzo, Francesco, et al.
Publicado: (2021) -
Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
por: Magliozzi, Roberta, et al.
Publicado: (2020) -
Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly Diagnosed RRMS Patients
por: Pitteri, Marco, et al.
Publicado: (2019)